Clik here to view.
The promise of improving outcomes for cancer patients through the liquid biopsy
This week’s publication in Nature is another major step towards the promise of the liquid biopsy. The study shows that the residual DNA fragments from cancer cells which are found in a patient’s blood...
View ArticleClik here to view.
Reflections on cell-free synthetic biology
Cell-free synthetic biology is a young but burgeoning sub-field of synthetic biology and has seen rapid and exciting progress in recent years. As the name implies, cell-free synthetic biology involves...
View ArticleVlog: episodic or continuous healthcare – which is sustainable?
Healthcare is changing. We – as consumers, rather than patients – need to manage health throughout our lives, rather than simply being treated at the point of illness. Following Prof Dame Sally...
View ArticleClik here to view.
Liquid biopsy shows great promise for cancer diagnostics
The recent results from tests run at the Francis Crick Institute in London, after a trial funded by Cancer Research UK , present further evidence of the ability of liquid biopsy to detect the presence...
View ArticleClik here to view.
Synthetic biology start-ups in the UK – going from strength to strength
The launch later this week of SynbiCITE’s UK Synbio Start-up Survey 2017 is a timely opportunity to recap on some of the most exciting developments in British Synthetic Biology. The UK has a fantastic...
View ArticleClik here to view.
4 reasons why rare paediatric disease drugs will benefit from drug delivery...
Drugs designated orphan status by FDAIncluding drugs not yet approved (data up to August 2017). Source FDA’s orphan drug product designation database. Rare diseases and orphan drugs have recently been...
View ArticleClik here to view.
Personalised ablation platforms: the untapped potential
If you care about precision medicine, then you care about medical devices. And, in today’s MedTech climate, if you care about medical devices, then it is an exciting time to care about ablation...
View ArticleClik here to view.
Industrial biotech – fear, doubt and saving the world
Last week, as part of Cambridge Consultants’ Synthetic Biology initiative, James Hallinan and I attended the Commercialising Industrial Biotechnology conference in San Diego. This bi-annual meeting...
View ArticleClik here to view.
Engineering a Better Meeting: A Human Factors Perspective to Meeting Efficacy
Most of us have been in a meeting that has not gone as planned. Topics came up that weren’t on the agenda, the meeting was hijacked by a strong personality, or a variety of other unexpected situations...
View ArticleClik here to view.
Four technologies that will attract interest at this year’s PDA Universe of...
The PDA’s Universe of Pre-filled Syringes and Injection Devices is around the corner and what a great opportunity to reveal what will shape the future of Drug Delivery. I have identified 4 technologies...
View Article
